Jeffrey Scott Engelsgjerd

Jeffrey Engelsgjerd practices at Essentia Health-Duluth (Miller-Dwan, Building D) in Duluth, Minnesota, part of Essentia Health.

Jeffrey Engelsgjerd's NPI, 1487682381, was assigned on June 29, 2006. Jeffrey Engelsgjerd graduated from University Of Minnesota Medical School in 1990. Jeffrey Engelsgjerd holds Minnesota license 38809.

Jeffrey Engelsgjerd's primary practice is Essentia Health-Duluth (Miller-Dwan, Building D), at 502 East Second Street, Duluth, MN 55805 in St. Louis County. The practice phone is (218) 786-2652.

Jeffrey Engelsgjerd's primary practice is Essentia Health-Duluth (Miller-Dwan, Building D) in Duluth, Minnesota, part of Essentia Health. Jeffrey Engelsgjerd is also affiliated with Essentia Health-St. Mary's Medical Center. The medical group on file is Essentia Health-Duluth Clinic. Dmand AI also links Jeffrey Engelsgjerd to 4 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jeffrey Engelsgjerd practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Jeffrey Engelsgjerd's primary specialty in the NPI Registry, under taxonomy code 208800000X. Jeffrey Engelsgjerd is board certified in urology by the American Board of Urology. Dmand AI has Jeffrey Engelsgjerd's licenses on file in 2 states: Minnesota and Wisconsin.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney stone disease, prostate surgery, urinary endoscopy and urine flow blockage among the conditions Jeffrey Engelsgjerd treats.

CMS data shows 252 Medicare services from Jeffrey Engelsgjerd across 8 procedure codes in 2024, for 167 Medicare patients. Medicare paid $11,487 for them.

CMS counts 167 Medicare patients who saw Jeffrey Engelsgjerd in 2024. The largest group is 65 to 74, with 71 patients. 65% of them have high blood pressure, and 58% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jeffrey Engelsgjerd's median patient age at 74, with 21% women.

In 2024, Jeffrey Engelsgjerd wrote 555 Medicare Part D claims for 172 patients. 98% of them were for generic drugs. CMS names the drug for 496 of them, across 9 drugs with 11 or more claims each, at $7,882 in total drug cost. In 2023, CMS named 469 claims across 10 drugs.

Jeffrey Engelsgjerd accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jeffrey Engelsgjerd as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Jeffrey Engelsgjerd.

CMS Open Payments shows 9 general payments to Jeffrey Engelsgjerd from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. PROCEPT BioRobotics Corporation paid the most, $222.

Dmand AI lists 2 awards for Jeffrey Engelsgjerd, most recently Regional Top Doctor in 2014.

Jeffrey Engelsgjerd graduated from University Of Minnesota Medical School in 1990.

Jeffrey Engelsgjerd is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Medica. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.